Dr. Arcadi Navarro, director of the BBRC, has been appointed to the Scientific Council of the CaixaResearch Institute, the first center specializing entirely in immunology in Spain and Portugal, promoted by the "la Caixa" Foundation
Fluid biomarkers remain highly valuable but are not yet sensitive enough to detect the earliest tau changes.
In this document we summarise the most important activities of 2025, a year marked by significant scientific advances in the field of Alzheimer's, support for affected individuals and families, and the growth of social support for our cause
The Barcelona Alzheimer’s HUB, supported by the Pasqual Maragall Foundation and the Barcelonaβeta Brain Research Center, held the second session of its scientific series at its headquarters, focusing on the study of fluid biomarkers.
An international study involving data from the ALFA+ cohort shows that the combination of physical and social environmental exposures is a major driver of accelerated or delayed brain aging.
A study by the BBRC shows that the genetic risk of Alzheimer’s disease may manifest itself differently in women and men, paving the way for more personalised prevention strategies.
The call provides up to €400,000 for clinical and translational research in Alzheimer’s disease and related dementias
BBRC researchers contributed to the AD/PD 2026 International Conference with four oral presentations and two posters.
The BBRC consolidates seven groups and expands its focus toward prevention and brain health from a comprehensive and longitudinal perspective